Bone Loss Completed Phase 2 Trials for Alendronic acid (DB00630)
Also known as: Osteopenia / Osteopenia (disorder) / Osteopenia (morphologic abnormality) / Osteopaenia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0031952 (Bone Loss) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02195895 | Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide | Treatment |